After launching in 2016 with GP internal capital, Oceanpine announced a final closing of its Oceanpine Capital Fund II totaling $400 million.
The Beijing-based firm invests in the DeepTech arena and innovative growth companies in both TMT and biotechnology sectors that have been so popular as of late. Its inaugural fund launched with $400 million with founder capital.
Investors in the second fund includes institutional investors from the U.S. and Asia, including insurance companies, technology leaders, family . . .
Continue Reading
Unlock this article instantly, along with the rest of our premium content and benefits including daily/weekly/monthly newsletters.
Monthly
$30
A pay-as-you-go plan to get you started
→ Instantly unlock all new and archived articles
→ Daily, weekly and monthly e-mail newsletters
→ Access to the weekly AW Deal Watch by AW Research
Annual
$300
Required for access to AW Research
Get more for less - 20% discount over monthly
→ Everything in Monthly PLUS:
→ Access to articles and data from AW Research
→ AW Annual Investor Compendium – our comprehensive guide to investor activity, with a ranking of the most active investors for the year and profiles of the top global allocators
